Isolated antiplasmin deficiency presenting as a spontaneous bleeding disorder in a 63-year-old man

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 8, 2006, Pages 673-675

  Harish, Vallathucherry C ^a,b   Zhang, Lin ^a   Huff, Jason D ^a   Lawson, Heather ^a   Owen, John ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Section on Hematology and Oncology   (United States)

Author keywords

Antifibrinolytics; Antiplasmin; Bleeding disorder; Polymorphism

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ANTIPLASMIN;

ADULT; ANAMNESIS; ARTICLE; BLEEDING DISORDER; BLOOD DONOR; BLOOD EXAMINATION; CASE REPORT; CLINICAL FEATURE; DNA POLYMORPHISM; GENE DELETION; HEMATOMA; HEMOSTASIS; HUMAN; LABORATORY TEST; LOW DRUG DOSE; MALE; MULTIPLE ORGAN FAILURE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEPSIS; TREATMENT RESPONSE;

AMINOCAPROIC ACIDS; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; BLOOD COAGULATION DISORDERS; HEMATOMA; HUMANS; MALE; MIDDLE AGED;

EID: 33751063883     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3280108e1a     Document Type: Article

References (16)

1. Griffin GC, Mammen EF, Sokol RJ, Perrotta AL, Stoyanovich A, Abildgaard CF. Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage. Am J Pediatr Hematol Oncol 1993; 15:328-330.
2. Hirosawa S, Nakamura Y, Miura O, Sumi Y, Aoki N. Organization of the human alpha 2-plasmin inhibitor gene. Proc Natl Acad Sci U S A 1988; 85:6836-6840.
3. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-386.
4. Hecker KH, Roux KH. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques 1996; 20:478-485.
5. Bangert K, Johnsen AH, Christensen U, Thorsen S. Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma. Biochem J 1993; 291 (Pt 2):623-625.
6. Lind B, Thorsen S. A novel missense mutation in the human plasmin inhibitor (alpha2-antiplasmin) gene associated with a bleeding tendency. Br J Haematol 1999; 107:317-322.
7. Holmes WE, Nelles L, Lijnen HR, Collen D. Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin). J Biol Chem 1987; 262:1659-1664.
8. Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69:209-216.
9. Aoki N, Yamanaka T. The alpha2-plasmin inhibitor levels in liver diseases. Clin Chim Acta 1978; 84:99-105.
10. Welch SK, Francke U. Assignment of the human alpha 2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids. Genomics 1992; 13:213-214.
11. Lee KN, Jackson KW, Christiansen VJ, Lee CS, Chun JG, McKee PA. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 2006; 107:1397-1404.
12. Sumi Y, Ichikawa Y, Nakamura Y, Miura O, Aoki N. Expression and characterization of pro alpha 2-plasmin inhibitor. J Biochem (Tokyo) 1989; 106:703-707.
13. Favier R, Aoki N, de Moerloose P. Congenital alpha(2)-plasmin inhibitor deficiencies: a review. Br J Haematol 2001; 114:4-10.
14. Aoki N. Genetic abnormalities of the fibrinolytic system. Semin Thromb Hemost 1984; 10:42-50.
15. Ikematsu S, Fukutake K, Aoki N. Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age. Thromb Res 1996; 82:129-116.
16. Bajaj SP, Rapaport SI, Barclay S, Herbst KD. Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management. Blood 1985; 65:1538-1543.